This report contains market size and forecasts of Prostate Cancer Vaccines in global, including the following market information:
Global Prostate Cancer Vaccines Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Prostate Cancer Vaccines Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Prostate Cancer Vaccines companies in 2021 (%)
The global Prostate Cancer Vaccines market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Tablet Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Prostate Cancer Vaccines include Dendreon Corporation, Bavarian Nordic, Advantagene, OncBioMune Pharmaceuticals, Advaxis immunotherapies, SOTIO, Cleveland BioLabs Inc., Curevac AG and Mediolanum Farmaceutici, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Prostate Cancer Vaccines manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Prostate Cancer Vaccines Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Prostate Cancer Vaccines Market Segment Percentages, by Type, 2021 (%)
Tablet
Injection
Global Prostate Cancer Vaccines Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Prostate Cancer Vaccines Market Segment Percentages, by Application, 2021 (%)
Hospital
Clinic
Others
Global Prostate Cancer Vaccines Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Prostate Cancer Vaccines Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Prostate Cancer Vaccines revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Prostate Cancer Vaccines revenues share in global market, 2021 (%)
Key companies Prostate Cancer Vaccines sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Prostate Cancer Vaccines sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Dendreon Corporation
Bavarian Nordic
Advantagene
OncBioMune Pharmaceuticals
Advaxis immunotherapies
SOTIO
Cleveland BioLabs Inc.
Curevac AG
Mediolanum Farmaceutici
Pfizer Inc.
Vaccitech
Sensei Biotherapeutics
Medigene AG
Ultimovacs
Oncovir Inc.
UbiVac
Momotaro-Gene Inc.
Vaccibody AS
AlphaVax Inc.